RxDoctor Payments Data

Tarah Sellner

Family · Pueblo, CONPI 1659865533

Payments from drug & device makers

$6,208in general payments, 2019–2025

Across 407 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$700
  • Novo Nordisk$673
  • Pfizer$530
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$316
  • Johnson & Johnson$305
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$6,208100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,208 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$52,572
Medicare patients
186
Services billed
1,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide83$128,244
EliquisApixaban55$52,596
XareltoRivaroxaban31$41,393
FarxigaDapagliflozin Propanediol30$36,159
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$30,432
TrulicityDulaglutide21$29,190
MounjaroTirzepatide22$29,186
JardianceEmpagliflozin11$18,264
JanumetSitagliptin Phos/Metformin Hcl16$13,176
LinzessLinaclotide16$9,901
ContraveNaltrexone Hcl/Bupropion Hcl11$7,518
Spiriva RespimatTiotropium Bromide11$5,457
BelsomraSuvorexant13$5,443
Lantus SolostarInsulin Glargine,hum.Rec.Anlog38$4,471
Pregabalin101$3,632

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$673$128,24483 claims
Lilly USA, LLCTrulicity, Mounjaro$216$58,37743 claims
PfizerEliquis$530$52,59655 claims
Johnson & JohnsonXarelto$305$41,39331 claims
AstraZenecaFarxiga$700$36,15930 claims
GSKTrelegy Ellipta$230$30,43231 claims
Boehringer IngelheimJardiance, Spiriva Respimat$27$23,72122 claims
MerckJanumet, Belsomra$48$18,61929 claims
AbbVieLinzess$1,224$9,90116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,182 family providers in Colorado.

Other family in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →